Seer to Report First Quarter Financial Results on May 4, 2022

Rhea-AI Summary

Seer Inc. (NASDAQ: SEER) will report its Q1 2022 financial results on May 4, 2022, followed by a conference call at 2:00 p.m. Pacific Time. The company is known for its innovative Proteograph Product Suite, designed for advanced proteomic analysis. This technology allows for deep, unbiased research capabilities, making it accessible to laboratories worldwide. The company emphasizes its focus on research use only, with no current diagnostic applications.

Positive

• Seer's Proteograph Product Suite offers advanced proteomic analysis capabilities.
• The upcoming financial results announcement shows transparency and engagement with investors.

Negative

• None.

REDWOOD CITY, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the first quarter of 2022 on Wednesday, May 4, 2022. Company management will be webcasting a conference call beginning at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.

Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.

About Seer

Seer™ is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph™ Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Investor Contact
Carrie Mendivil
investor@seer.bio

Media Contact
Karen Possemato
pr@seer.bio

FAQ

What date will Seer Inc. announce its Q1 2022 financial results?

Seer Inc. will announce its Q1 2022 financial results on May 4, 2022.

What is the purpose of the Proteograph Product Suite offered by Seer Inc.?

The Proteograph Product Suite is designed for deep, unbiased proteomic analysis for research use only.

What time will the conference call for Seer's financial results begin?

The conference call will begin at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.

Where can I listen to Seer's financial results webcast?

The live audio of the webcast will be available on the Investor section of Seer’s website.